Curcumin and hypertriglyceridemia

Phase 2

Not yet recruiting

• Conditions: Hypertriglyceridemia.; Pure hyperglyceridaemia; E78.1

• Registration Number: IRCT2015071314521N4
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age 18-65 years
Fasting serum TG>150 mg/dl
Using Statin drugs

Exclusion Criteria

Unwillingness to participate in the study
Sensitivity to herbal supplements

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: before the intervention. Method of measurement: enzymatic experimental kit.

Secondary Outcome Measures

Name	Time	Method
FBG. Timepoint: 2 months after the intervention. Method of measurement: enzymatic experimental kit.;Insulin. Timepoint: 2 months after the intervention. Method of measurement: radioimmunoassay experimental kit.;Total cholesterol. Timepoint: 2 months after the intervention. Method of measurement: enzymatic experimental kit.;HDL-C. Timepoint: 2 months after the intervention. Method of measurement: enzymatic experimental kit.;LDL-C. Timepoint: 2 months after the intervention. Method of measurement: enzymatic experimental kit.;HS-CRP. Timepoint: 2 months after the intervention. Method of measurement: ELISA experimental kit.;Body mass index. Timepoint: 2 months after the intervention. Method of measurement: weight (kg) / height2 (m).